Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Terrie Curran

Director at Arcutis Biotherapeutics, Inc. (ARQT)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $984K

Reported trades

Filed Stock Type Shares Price Value Since
Aug 28SEC ARQTArcutis Biotherapeutics, Inc. Sell 11,14823,526 held (−32%) $25.03 $279K +15.1%
Aug 28SEC ARQTArcutis Biotherapeutics, Inc. Sell 27,05223,526 held (−53%) $25.03 $677K +15.1%
Aug 24SEC ARQTArcutis Biotherapeutics, Inc. Sell 1,07223,526 held (−4%) $26.04 $28K +10.7%
  • Sell

    Director Terrie Curran sold $279K of ARQT at $25.03 — cuts the stake by 32%.

  • Sell

    Director Terrie Curran sold $677K of ARQT at $25.03 — cuts the stake by 53%.